Singapore markets open in 8 hours 19 minutes
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,026.41 -45.22 (-0.89%) Dow
37,979.94 -480.98 (-1.25%) Nasdaq
15,506.78 -205.97 (-1.31%) Bitcoin USD
64,106.91 -630.47 (-0.97%) CMC Crypto 200
1,387.52 +4.94 (+0.36%)
Quoin Pharmaceuticals, Ltd. (QNRX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 12:40PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.33M |
| Enterprise value | -8.36M |
| Trailing P/E | 1.87 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.41 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.97 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.95 |
| 52-week change 3 | -89.75% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 12.0000 |
| 52-week low 3 | 0.6100 |
| 50-day moving average 3 | 1.4233 |
| 200-day moving average 3 | 4.0423 |
Share statistics
| Avg vol (3-month) 3 | 624.51k |
| Avg vol (10-day) 3 | 64.7k |
| Shares outstanding 5 | 3.69M |
| Implied shares outstanding 6 | 3.69M |
| Float 8 | 3.67M |
| % held by insiders 1 | 0.53% |
| % held by institutions 1 | 2.30% |
| Shares short (15 Apr 2024) 4 | 15.33k |
| Short ratio (15 Apr 2024) 4 | 0.13 |
| Short % of float (15 Apr 2024) 4 | 0.42% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.42% |
| Shares short (prior month 15 Mar 2024) 4 | 33.65k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 23 Oct 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:12 |
| Last split date 3 | 18 Jul 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -44.03% |
| Return on equity (ttm) | -132.92% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -9.27M |
| Net income avi to common (ttm) | -8.69M |
| Diluted EPS (ttm) | -9.6400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 10.69M |
| Total cash per share (mrq) | 2.9 |
| Total debt (mrq) | 3.52M |
| Total debt/equity (mrq) | 62.21% |
| Current ratio (mrq) | 3.15 |
| Book value per share (mrq) | 5.74 |
Cash flow statement
| Operating cash flow (ttm) | -7.86M |
| Levered free cash flow (ttm) | -4.68M |
© 2024 Yahoo. All rights reserved.